By Ambassador (ret.) Yoram Ettinger
1. According to KPMG, one of the four largest global auditing firms, Israel has become a leading hothouse for FinTech companies. 9 out of 100 globally-promising FinTech companies are from Israel, an improvement from 8/100 in 2015.
2. In defiance of the global financial downtrend – but as a derivative of Israel’s cutting-edge technologies - Israeli hightech companies raised $1.19BN during Q3 2016, the second highest quarterly amount in ten years. During the first nine months of 2016, Israeli hightech companies raised $4BN, 27% above the $3.15BN raised during the first nine months of 2015.
3. Boston Scientifics acquired Israel’s EndoChoice for $210MN (Globes, September 28).
4. The Lexington, MA and Dublin, Ireland-based, Shire, a biopharmaceuticals giant, extends its strategic partnership with Israel’s plasma-derived protein therapeutics company, Kamada, which is expected to yield a minimum of $237MN in revenues during 2017-2020 (Globes, Oct. 7).
5. According to Forbes, September 22 issue: “Since 2011, there has been a 50% year-on-year growth of Chinese investment in Israel….” For example, Li-Ka-Shing, the Hong-Kong-based tycoon, has invested – privately and via his venture capital fund, Horizon Ventures – in 30 Israeli companies.
Please click for the full document.